Prevalence ofBRCA1/2germline mutations in 21 401 families with breast and ovarian cancer-Reference-Cited by-同舟云学术

Prevalence ofBRCA1/2germline mutations in 21 401 families with breast and ovarian cancer

Published:2016-02-29 Issue:7 Volume:53 Page:465-471
ISSN:0022-2593
Container-title:Journal of Medical Genetics
language:en
Short-container-title:J Med Genet

Author:

Kast Karin,Rhiem Kerstin,Wappenschmidt Barbara,Hahnen Eric,Hauke Jan,Bluemcke Britta,Zarghooni Verena,Herold Natalie,Ditsch Nina,Kiechle Marion,Braun Michael,Fischer Christine,Dikow Nicola,Schott Sarah,Rahner Nils,Niederacher Dieter,Fehm Tanja,Gehrig Andrea,Mueller-Reible Clemens,Arnold Norbert,Maass Nicolai,Borck Guntram,de Gregorio Nikolaus,Scholz Caroline,Auber Bernd,Varon-Manteeva Raymonda,Speiser Dorothee,Horvath Judit,Lichey Nadine,Wimberger Pauline,Stark Sylvia,Faust Ulrike,Weber Bernhard H F,Emons Gunter,Zachariae Silke,Meindl Alfons,Schmutzler Rita K,Engel Christoph

Publisher

BMJ

Subject

Genetics(clinical),Genetics

Reference34 articles.

1. Meta-analysis of BRCA1 and BRCA2 penetrance;Chen;J Clin Oncol,2007

2. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction;Claus;Cancer,1994

3. Patients with double primary tumors in the breast and ovary-clinical characteristics and BRCA1-2 mutations status;Fishman;Gynecol Oncol,2000

4. and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium;Ford;Am J Hum Genet,1998

5. Linkage of early-onset familial breast cancer to chromosome 17q21;Hall;Science (New York, NY),1990

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction;The Breast;2024-02

2. Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond;Cancers;2024-01-30

3. Risk-adapted prevention in breast and ovarian cancer;Forum;2024-01-24

4. Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne;Cancer Medicine;2024-01-17

5. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study;Breast Cancer Research;2023-12-14